158 related articles for article (PubMed ID: 20211532)
1. Desvenlafaxine: a therapeutic option for treatment of menopausal hot flashes.
Archer DF
Maturitas; 2010 May; 66(1):1-2. PubMed ID: 20211532
[No Abstract] [Full Text] [Related]
2. Efficacy of desvenlafaxine succinate for menopausal hot flashes.
Tella SH; Gallagher JC
Expert Opin Pharmacother; 2014 Nov; 15(16):2407-18. PubMed ID: 25252697
[TBL] [Abstract][Full Text] [Related]
3. Is desvenlafaxine effective and safe in the treatment of menopausal vasomotor symptoms? A meta-analysis and meta-regression of randomized double-blind controlled studies.
Berhan Y; Berhan A
Ethiop J Health Sci; 2014 Jul; 24(3):209-18. PubMed ID: 25183927
[TBL] [Abstract][Full Text] [Related]
4. Flushing in a menopausal woman taking venlafaxine.
Grady-Weliky TA; Hartmann DM
Am J Psychiatry; 2001 Aug; 158(8):1330. PubMed ID: 11481177
[No Abstract] [Full Text] [Related]
5. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine for hot flushes.
Barlow DH
Lancet; 2000 Dec; 356(9247):2025-6. PubMed ID: 11145483
[No Abstract] [Full Text] [Related]
7. Nonhormonal agents show promise against hot flashes.
Gottlieb N
J Natl Cancer Inst; 2000 Jul; 92(14):1118-20. PubMed ID: 10904081
[No Abstract] [Full Text] [Related]
8. Venlafaxine hydrochloride for the treatment of hot flashes.
Schober CE; Ansani NT
Ann Pharmacother; 2003 Nov; 37(11):1703-7. PubMed ID: 14565812
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer and hot flashes. Options for relief.
Mayo Clin Health Lett; 2001 Mar; 19(3):6. PubMed ID: 11242843
[No Abstract] [Full Text] [Related]
10. Medroxyprogesterone acetate better than venlafaxine at relieving hot flashes.
J Support Oncol; 2005; 3(4):312. PubMed ID: 16092603
[No Abstract] [Full Text] [Related]
11. Beyond estrogen: new alternatives for the management of hot flashes.
Dvorak SR
S D J Med; 2002 Jan; 55(1):11-2. PubMed ID: 11808405
[No Abstract] [Full Text] [Related]
12. Concern about the use of venlafaxine to treat vasomotor symptoms.
Zhou SS; Lun YZ; Li D
JAMA Intern Med; 2015 Apr; 175(4):657-8. PubMed ID: 25844750
[No Abstract] [Full Text] [Related]
13. Concern about the use of venlafaxine to treat vasomotor symptoms--reply.
Joffe H; LaCroix AZ; Cohen L
JAMA Intern Med; 2015 Apr; 175(4):658-9. PubMed ID: 25844753
[No Abstract] [Full Text] [Related]
14. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
Pinkerton JV; Constantine G; Hwang E; Cheng RF;
Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.
Archer DF; Pinkerton JV; Guico-Pabia CJ; Hwang E; Cheng RF;
Menopause; 2013 Jan; 20(1):47-56. PubMed ID: 23266840
[TBL] [Abstract][Full Text] [Related]
16. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
[TBL] [Abstract][Full Text] [Related]
17. Treatment for hot flushes in women receiving tamoxifen.
Bydder SA; Spry NA
Med J Aust; 2002 Sep; 177(5):266. PubMed ID: 12197825
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of desvenlafaxine treatment for hot flashes associated with menopause: a meta-analysis of randomized controlled trials.
Sun Z; Hao Y; Zhang M
Gynecol Obstet Invest; 2013; 75(4):255-62. PubMed ID: 23548358
[TBL] [Abstract][Full Text] [Related]
19. Managing vasomotor symptoms in women after cancer.
Pinkerton JV; Santen RJ
Climacteric; 2019 Dec; 22(6):544-552. PubMed ID: 31081391
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
